Safety of First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817

Luis Paz‐Ares, Tudor–Eliade Ciuleanu, Adam Płużański, Jong‐Seok Lee, Justin F. Gainor, Gregory A. Otterson, Clarisse Audigier-Valette, Neal Ready, Michael Schenker, Helena Linardou, Reyes Bernabe Caro, Mariano Provencio, Bogdan Żurawski, Ki Hyeong Lee, Sang‐We Kim, Claudia Caserta, Suresh S. Ramalingam, David R. Spigel, Julie R. Brahmer, Martin Reck, Kenneth J. O’Byrne, Nicolas Girard, Sanjay Popat, Solange Peters, Arteid Memaj, Faith E. Nathan, Nivedita Aanur, Hossein Borghaei